Dr. Cyrus Crowder, Chair, International Centre for Diffraction Data, Newtown Square, PA, U.S.A.
Dr. Detlef Beckers, PANalytical, Almelo, The Netherlands
Dr. Julien Giovannini, AstraZeneca, Nottingham, U.K.
Dr. Arnt Kern, Bruker AXS GmbH, Karlsruhe, Germany
Ms. Terry Maguire, International Centre for Diffraction Data, Newtown Square, PA, U.S.A.
Dr. Fangling Needham, International Centre for Diffraction Data, Newtown Square, PA, U.S.A.
Dr. Kenneth Shankland, Reading University, Reading, U.K.
Dr. Gregory A. Stephenson, Eli Lilly and Company, Indianapolis, IN, U.S.A.
Dr. Raj Suryanarayanan, University of Minnesota, Minneapolis, MN, U.S.A.
Dr. Hideo Toraya, Rigaku Corporation, Tokyo, Japan
Dr. Peter G. Varlashkin, GlaxoSmithKline, Durham, NC, U.S.A.
Dr. Shawn Yin, Bristol-Myers Squibb Company, New Brunswick, NJ, U.S.A.
Bios of Organizing Committee
Dr. Cyrus Crowder - PPXRD Chair
International Centre for Diffraction Data, Newtown Square, PA, U.S.A.
Dr. Cyrus Crowder is currently the Principle Scientist of the International Centre for Diffraction Data. He received his BS in Chemistry at the University of Missouri - Rolla in 1976 and followed that with 2 years of teaching high school physical sciences and mathematics in Missouri. He returned to the University of Missouri - Rolla to receive an MS degree in Physical Chemistry in 1980 and a PhD in 1982 using neutron diffraction to do structural studies on magnetic intermetallics and their hydrides. Dr. Crowder joined the Dow Chemical Company in 1982 and has been active in the field of X-ray diffraction since that time. As a member of Dow’s Analytical Sciences Laboratory, he used various X-ray diffraction techniques to solve both R&D and production-related problems in the fields of polymer science, pharmaceuticals, catalysis, ceramics, electronics, and composite materials. He was co-winner of an IR-100 award in 1987 for his work on the development of the combination DSC/XRD instrument and co-winner of the International Zeolite Association Breck Award in 1989 for his determination of the structure of VPI-5 - a molecular sieve with the largest known pores at the time. Before his retirement from Dow in September 2007, his responsibilities included Global Technology Steward for X-ray diffraction and tomography and representative for Dow on the DND-Cat Board of Directors at the APS synchrotron, Argonne National Laboratory. He served for four years on the Board of Directors of the ICDD (1994-1998) and was elected ICDD Fellow in 2000. Dr. Crowder joined the ICDD as Principal Scientist in September of 2007 following his 25-year career at Dow.
Areas of expertise: XRD phase identification, phase quantitation by whole pattern methods, crystallography, synchrotron-based powder diffraction, combination thermal/phase analyses (DSC/XRD)
Ph.D. in physics at the Research Center Jülich, Solid State Physics Institute, Germany in 1996.
Joined PANalytical B.V. in 1996 (Philips Analytical B.V. at that time) in the position of project manager XRD (X-ray diffraction). At that time responsible for the management of hardware development projects and (pre-) development of new optical XRD modules. Currently in the position of Market Segment Manager Pharmaceuticals, Food and Life Science with the responsibilities for applications and business development and the co-ordination of the pharmaceutical, food and life science market activities within the company.
Bio coming soon
Bio coming soon
Dr. Needham currently is part of the software/database development team in the Science Department of the ICDD. She has also developed software/databases in the chemistry industry for PARC and PI. Dr. Needham's educational background includes a B.A. in Earth Science, Southern Connecticut State University, a Ph.D. in Organic Chemistry from Northeastern University and a post graduate certificate in Apply Science/Computer Science from Harvard University Extension. Her experience in research also includes an American Cancer Society Research Fellow on Breast Cancer Research as a graduate student at Northeastern University, a post doctorate research fellow on positron emission tomography at Massachusetts General Hospital, and teaching fellows in chemistry at Northeastern University, and computer science at Harvard University.
Areas of expertise: Organic chemistry, computer science, and basic crystallography
Kenneth recently left the STFC Rutherford Appleton Laboratory, after 15 years there, to take up a post as a Reader in Pharmaceutics at the School of Pharmacy at Reading University. His main scientific interests lie in the area of structures and transformations in pharmaceutical materials and he has been heavily involved in software development for crystallographic analysis of these and other systems. His work with Prof. Bill David of the STFC Rutherford Lab on the subject of global optimisation strategies for the structure determination of molecular materials from powder diffraction data led to the publication of several key papers in the field and ultimately to the production of the DASH software package which is now co-developed with CCDC. His underlying interest in the use of computing methodologies to further this work has seen particular utility in the development of highly parallelised versions of DASH and other closely-related codes that run on distributed computing systems. He is a keen user of laboratory-based X-ray diffraction equipment and a regular user of diffraction beamlines at central facilities.
Dr. Greg Stephenson received his Ph.D. degree in Medicinal Chemistry from Purdue University where he conducted his graduate research under the advisement of Professor Stephen Byrn. In 1994, he joined Eli Lilly and Company's Preformulation department where he is a Research Advisor responsible for the discovery and characterization of salts and polymorphic forms of potential drug substances. Much of his work centers around the application of solid state techniques such as Single Crystal and Powder X-ray Diffraction, and 13C solid-state NMR spectroscopy to better understand physical properties of pharmaceuticals. Greg has published over 60 peer-reviewed research articles and patents, serves as Associate Editor for the Journal of Pharmaceutical Sciences, and is an elected Fellow for the ICDD.
Raj Suryanarayanan (Sury) is Professor of Pharmaceutics in the College of Pharmacy, University of Minnesota. He also holds the William and Mildred Peters Endowed Chair in Pharmaceutics. He obtained his B.Pharm. and M.Pharm. degrees from Banaras Hindu University, Varanasi, India and M.Sc. and Ph.D. degrees in Pharmaceutics from University of British Columbia, Vancouver, Canada. His research is focused in the area of solid-state properties of drugs. His publications in this field deal with phase transitions in solids, implications of in situ phase transitions on product performance, evaluation of concepts of crystallinity and development of new techniques to evaluate crystallinity in solids. He has developed X-ray diffractometric techniques for the qualitative and quantitative analyses of solid phases, to determine the drug content in intact tablets and to study solid-state reactions. His research group is currently involved in developing low temperature powder X-ray diffractometric techniques to study frozen and freeze-dried pharmaceutical systems. He is a consultant to numerous pharmaceutical companies and has served as a member of the USP Expert Committee (Excipients test methods). He is a fellow of the AAPS and is the past-chair of the Teachers of Pharmaceutics Section of the American Association of Colleges of Pharmacy.
Bio coming soon
Dr. Peter Varlashkin obtained his Ph.D. in Analytical Chemistry from the University of Tennessee (Knoxville). After a post-doctoral appointment at NYU, he joined GlaxoSmithKline (RTP, NC, U.S.A. ) in April 1986. Except for a 2-year stint at Metrics, Inc., a contract pharmaceutical organization, from 2004 to 2006, he has been an employee of GSK working in the analytical and physical properties characterization of active pharmaceutical ingredients and drug products.
Dr. Shawn (Xiaotian) Yin received his Ph. D. in Solid-State Chemistry from University of Waterloo, Canada. He did his Post Doctoral fellowship at Department of Materials Sciences and Engineering, Cornell University, U.S. Currently, Dr. Yin is a Principal Scientist and the group leader of Crystal Form Chemistry and Characterization group at Bristol-Myers Squibb Company. His research interests include pharmaceutical polymorphic form studies, pre-formulation work, nanomaterials for drug delivery, physical characterizations of pharmaceutical substances and powder X-ray diffraction applications in pharmaceutical sciences.
Dr. Yin has (co)-authored 15 scientific publications and 8 patents. He serves as a scientific organization committee member for the Pharmaceutical Powder X-ray Diffraction Symposium. Dr. Yin is also a frequent invited lecturer at international and domestic scientific conferences and workshops.